The Community Preventive Services Task Force (CPSTF) released a recommendation that the health care system incorporate tailored pharmacy-based interventions for cardiovascular disease (CVD) prevention into overall prevention efforts.

Fourteen national pharmacy associations, including APhA, have signed onto a joint statement against racial injustice.

New research published recently in the Journal of the American Heart Association found that some heart medications, including statins, aspirin, and blood pressure medications, were prescribed less frequently to women than to men.

In a letter directed to congressional leaders on May 7, 2020, more than 240 patient advocacy and health care groups urged inclusion of DIR fee reform in the next coronavirus economic stimulus bill.

On March 22, FDA issued new guidance on required testing for the Risk Evaluation and Mitigation Strategy (REMS) program.